Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track TECH with free AI briefings, catalyst countdowns, and dilution alerts.

TECH · Bio-Techne Corp

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$350M Cash on Hand
CF+ Cash Runway
Follow TECH by email Get an email when TECH reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about TECH, unsubscribe in one click. Privacy

📣 What TECH Says Is Next

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

TECH holds $350M in cash and short-term investments (as of Sep 30, 2026) and its operations are currently cash-flow neutral or positive.

Dilution pressure: 0 · Low

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when TECH files for a raise →

👥 Who Owns TECH

Insiders 0.3% Institutions (805 holders) 99.7% Public and other holders 0%
HolderTypeShares% of sharesAs of
Vanguard Capital Management Institution (13G, 5%+) 11,559,571 7.36% 2026-03-31
James Hippel
CFO · +440,138 options
Insider 176,720 0.11% 2026-11-01
Kim Kelderman
Chief Executive Officer, Director · +620,879 options
Insider 80,509 0.05% 2026-11-01
John L Higgins
Director · +51,381 options
Insider 80,004 0.05% 2026-10-29
Robert V Baumgartner
Director · +51,381 options
Insider 59,634 0.04% 2026-10-29
William Geist
PRESIDENT, PROTEIN SCIENCES · +166,752 options
Insider 24,943 0.02% 2026-08-17
Alpna Seth
Director · +31,289 options
Insider 18,161 0.01% 2026-10-29
Joseph D Keegan
Director · +51,381 options
Insider 18,161 0.01% 2026-10-29
Rupert Vessey
Director · +33,641 options
Insider 13,737 0.01% 2026-10-29
Julie L Bushman
Director · +24,689 options
Insider 11,525 0.01% 2026-10-29
Shane Bohnen
SVP - General Counsel · +96,966 options
Insider 10,360 0.01% 2026-08-17
Steven C. Crouse
President - Diag & Spatial Bi · +127,580 options
Insider 10,237 0.01% 2026-08-17

Share count 157,090,727 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full TECH picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for TECH and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.